MAPK3 and Hyperglycemia: Additionally, HG promotes ERK1/2 phosphorylation [48], and the ERK1/2 inhibitor U0126 abrogated NF-κB activation in HG-treated BV2 cells [53], indicating the activation of a microglial ERK/NF-κB pathway by hyperglycemia.